Navigation Links
Drugs from the sea: New discoveries in marine biomedicine
Date:5/13/2011

Substances produced by living organisms found in natureso-called "natural products"have played a critical role in the development of drugs for life-threatening conditions. The anticancer agent Taxol was sourced from a plant, penicillin from a fungus, and a number of recent breakthroughs have resulted in the development and approval of anticancer drugs derived from marine sources such as coral and sponges.

To raise awareness about the vast potential of marine- and natural product-based biotechnology in the discovery and development of new drugs, the New York Academy of Sciences and the marine-based drug development company Zeltia S.A. are hosting a symposium, "New Frontiers in Marine Drug Discovery" at the New York Academy of Sciences Conference Center on May 20, 2011. This symposium will address the newly discovered and tremendous potential that the biodiversity of the marine ecosystem offers as a source for new therapeutically useful compounds, from the early stage drug discovery perspective of academia and the clinical therapy development perspective of industry.

The event will showcase recent technological improvements in natural product chemistry; review the landscape of marine-derived compoundsboth approved drugs and those in the development and trial stages; and explore examples of pioneering efforts, failures and successes in the translation of small molecules of natural marine origin into first-in-class and life-changing therapies for metastatic ovarian and metastatic breast cancer, among other diseases.

WHAT: A Scientific Symposium: New Frontiers in Marine Drug Discovery

WHO:

  • William Fenical, PhD, Director, Scripps Institution of Oceanography
  • Shirley Pomponi, PhD, President and CEO, Harbor Branch Oceanographic Institution
  • Juli M. Trtanj, Director, Oceans and Human Health Initiative, NOAA National Ocean Service
  • Roberto Weinmann, PhD, COO PharmaMar USA, a company of the Zeltia Group

WHEN: Friday May 20, 2011 | 8:00 AM - 7:00 PM

WHERE:
The New York Academy of Sciences
7 World Trade Center, 250 Greenwich St., 40th floor, New York, NY


'/>"/>

Contact: Marta Murcia
mmurcia@nyas.org
212-298-8641
New York Academy of Sciences
Source:Eurekalert

Related biology news :

1. Cholesterol-lowering drugs and the effect on muscle repair and regeneration
2. Vitamin C supplements may reduce benefit from wide range of anti-cancer drugs
3. Discovering drugs, biofuels in tropical seas
4. Academy participates in project to discover drugs, biofuels in tropical seas
5. European researchers harness unique properties of boron to develop new drugs and diagnostics
6. Self-assembling nano-fiber gel delivers high concentrations of clinically approved drugs
7. Moderate use averts failure of type 2 diabetes drugs in animal model
8. Montana State University researchers find gene that regulates molds resistance to drugs
9. MSU researcher studies ties between cholesterol drugs, muscle problems
10. New technique eliminates toxic drugs in islet transplant in diabetic mice
11. REGiMMUNE receives $12 million in grants to develop transplant and allergy drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2016)... March 29, 2016 LegacyXChange, Inc. ... "LEGX" and SelectaDNA/CSI Protect are pleased to announce our ... in a variety of writing instruments, ensuring athletes signatures ... created collectibles from athletes on LegacyXChange will be assured ... the DNA. Bill Bollander , CEO ...
(Date:3/21/2016)... WAKEFIELD, Massachusetts , March 22, 2016 ... and facial recognition with passcodes for superior security ... MESG ), a leading provider of secure digital communications ... pilot their biometric technology and offer enterprise customers, particularly ... provide secure facial recognition and voice authentication within a ...
(Date:3/15/2016)... , March 15, 2016 Yissum Research ... the technology-transfer company of the Hebrew University, announced today ... remote sensing technology of various human biological indicators. Neteera ... $2.0 million from private investors. ... on the detection of electromagnetic emissions from sweat ducts, ...
Breaking Biology News(10 mins):
(Date:5/26/2016)... ... May 26, 2016 , ... Kinder ... several positive developments that position the Company for the future. Kinder Scientific ... Craig F. Kinghorn has been appointed Chairman of the Board, Curtis D. Kinghorn ...
(Date:5/25/2016)... ... May 25, 2016 , ... ... recently became double board-certified in surgery and surgery of the hand by the ... is no stranger to going above and beyond in his pursuit of providing ...
(Date:5/25/2016)... New Haven, Connecticut (PRWEB) , ... May 25, ... ... today that the U.S. Food and Drug Administration (FDA) has granted the company’s ... This is the company’s second orphan drug designation granted by the FDA. ...
(Date:5/23/2016)... ... 23, 2016 , ... The need for blood donations in South Texas and across the nation ... Blood & Tissue Center, blood donations are on the decline. In fact, donations across the ... 21 percent in South Texas in the last four years alone. , There is no ...
Breaking Biology Technology: